Skip to Content

Aurora Cannabis upgraded to neutral at MKM Partners

MKM Partners analyst Bill Kirk on Tuesday upgraded shares of Aurora Cannabis (ACB.T) to neutral from sell and increased his fair value price for the stock from C$6 to C$7 after the Canadian cannabis company reported a narrower than expected EBITDA loss of C$13.9 million, compared to the consensus estimate for a loss of C$16.9 million. Kirk said Aurora continues to face a struggling recreational-use business, and despite a consistent medical business, sees volatility in the international market. Aurora is the only stock in the firm's 22-name coverage universe without a single "buy" rating. Aurora Cannabis shares fell 2.3% in pre-market trades.

-Steve Gelsi


(END) Dow Jones Newswires

09-28-21 0735ET

Copyright (c) 2021 Dow Jones & Company, Inc.